skyrizi and tirzepatide Pharma 50: Keytruda holds the top brand slot, but semaglutide have already passed it at the molecule level in FY2025 Skyrizi (risankizumab-rzaa) treatment of plaque
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2



























